Gene Therapy

Gene Therapy

基因治疗

  • 3区 中科院分区
  • Q1 JCR分区

期刊简介

《Gene Therapy》是由Springer Nature出版社于1997年创办的英文国际期刊(ISSN: 0969-7128,E-ISSN: 1476-5462),该期刊长期致力于生物工程与应用微生物领域的创新研究,主要研究方向为医学-生化与分子生物学。作为SCIE收录期刊(JCR分区 Q1,中科院 3区),本刊采用OA未开放获取模式(OA占比0.2570...%),以发表生物工程与应用微生物领域等方向的原创性研究为核心(研究类文章占比90.91%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在44篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Gene Therapy审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约44篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 44 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 GENETICS & HEREDITY 遗传学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
2区 3区 3区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物 GENETICS & HEREDITY 遗传学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区 3区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 74 / 313

76.5%

学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 31 / 174

82.5%

学科:GENETICS & HEREDITY SCIE Q1 35 / 191

81.9%

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 49 / 189

74.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q1 73 / 313

76.84%

学科:BIOTECHNOLOGY & APPLIED MICROBIOLOGY SCIE Q1 41 / 174

76.72%

学科:GENETICS & HEREDITY SCIE Q2 48 / 191

75.13%

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 50 / 189

73.81%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:9.7 SJR:1.671 SNIP:1.108
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Genetics Q1 46 / 347

86%

大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Biology Q1 81 / 410

80%

大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Medicine Q1 37 / 178

79%

期刊发文

  • E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis

    Author: Gao, Qianfu; Wang, Shanchao; Zhang, Zeyan

    Journal: GENE THERAPY. 2023; Vol. 30, Issue 1-2, pp. 51-63. DOI: 10.1038/s41434-021-00289-z

  • Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy

    Author: Tian, Limin; Liu, Tianyan; Jiang, Shan; Cao, Yukai; Kang, Kai; Su, Han; Ren, Guiping; Wang, Zhenzhong; Xiao, Wei; Li, Deshan

    Journal: GENE THERAPY. 2023; Vol. 30, Issue 1-2, pp. 64-74. DOI: 10.1038/s41434-021-00256-8

  • Overexpressed ski efficiently promotes neurorestoration, increases neuronal regeneration, and reduces astrogliosis after traumatic brain injury

    Author: Zhai, Yu; Ye, Shi-Yang; Wang, Qiu-Shi; Xiong, Ren-Ping; Fu, Sheng-Yu; Du, Hao; Xu, Ya-Wei; Peng, Yan; Huang, Zhi-Zhong; Yang, Nan; Zhao, Yan; Ning, Ya-Lei; Li, Ping; Zhou, Yuan-Guo

    Journal: GENE THERAPY. 2023; Vol. 30, Issue 1-2, pp. 75-87. DOI: 10.1038/s41434-022-00320-x

  • Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease

    Author: Jin, Rujue; Zhu, Weigang; Xu, Jiajun; Gu, Jianhui; Deng, Aidong

    Journal: GENE THERAPY. 2023; Vol. 30, Issue 1-2, pp. 31-40. DOI: 10.1038/s41434-022-00330-9

  • Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21

    Author: Wang, Haojie; Qi, Yijun; Lan, Zijun; Liu, Qiwei; Xu, Juanjuan; Zhu, Mengxi; Yang, Tingting; Shi, Ruolin; Gao, Shegan; Liang, Gaofeng

    Journal: GENE THERAPY. 2023; Vol. 30, Issue 1-2, pp. 88-100. DOI: 10.1038/s41434-022-00331-8

  • Forced activation of dystrophin transcription by CRISPR/dCas9 reduced arrhythmia susceptibility via restoring membrane Nav1.5 distribution

    Author: Zhang, Ruixin; Liu, Junwu; Xue, Genlong; Yang, Jiming; Li, Desheng; Tian, Tao; Zhang, Xiaofang; Gao, Kangyi; Pan, Zhenwei

    Journal: GENE THERAPY. 2023; Vol. 30, Issue 1-2, pp. 142-149. DOI: 10.1038/s41434-022-00348-z

  • Identification of RPGR ORF15 mutation for X-linked retinitis pigmentosa in a large Chinese family and in vitro correction with prime editor

    Author: Lv, Xiujuan; Zheng, Zheng; Zhi, Xiao; Zhou, Yilin; Lv, Jineng; Zhou, Yue; Wu, Binrong; Liu, Sixiu; Shi, Wei; Song, Zongming; Xu, Jinling; Qu, Jia; Xu, Dan; Gu, Feng

    Journal: GENE THERAPY. 2023; Vol. 30, Issue 1-2, pp. 160-166. DOI: 10.1038/s41434-022-00352-3

  • Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model

    Author: Gong, Jie; Liu, Yunyun; Chung, Tsai-Hua; Xu, Liu; Lund, Troy C.; Chang, Lung-Ji

    Journal: GENE THERAPY. 2023; Vol. 30, Issue 1-2, pp. 18-30. DOI: 10.1038/s41434-022-00355-0